The discovery of five distinct subtypes of breast carcinomas (Luminal A, Luminal B, HER2 over-expression, Basal-like, and Normal-like) using whole-genome analysis; each with unique recognizable phenotypes and clinical outcomes [27]. This evidence concerns the gene ERBB2 and breast carcinoma.